It looks like you have an older browser that is not supported by this site. Please click here to update.
On May 12, 2020, the Indiana State Department of Health (ISDH) issued a document providing guidance on mitigating the use of aerosolizing respiratory treatments in long-term care facilities to minimize the risk of COVID-19 transmission, including the administration of inhaled medications via nebulizer therapy and noninvasive airway support via C-PAP and Bi-PAP.
The current recommended best practice is to shift to the use of Metered-Dose Inhalers, as opposed to nebulized treatments, for all long-term care residents, as applicable, in consultation with the resident’s medical provider.
In circumstances that require nebulizer therapy, if a resident is confirmed or suspected to be COVID-positive, the guidance offers the following strategies:
To assist health care personnel who perform or assist with aerosolizing producing procedures, IHCA/INCAL also recommends reviewing Item #11 in the CDC’s Guidance for Infection Control in Health Care Facilities, which further specifies the PPE that should be used for aerosol-generating procedures. If you have any questions, please contact Lori Davenport at email@example.com.